The INCISIVE pilots will focus on the following types of cancer: lung, colorectal, breast and prostate. They will be carried out in 8 pilot sites in Greece, Italy, Spain, Cyprus and Serbia, following all applicable ethical procedures, along with privacy and security protocols.

All pilots will be deployed in two phases. In the first phase, an observational study will be performed where the INCISIVE processing pipelines will be used retrospectively to evaluate the proposed system performance, added value and identify novel, potentially valuable prognostic markers. In the second phase, a short interventional study with a small number of participants will allow the use of the INCISIVE AI tools in practice, thus providing additional summative evaluation data for the developed techniques